113 related articles for article (PubMed ID: 36204642)
1. Comprehensive analysis of a TPX2-related TRHDE-AS1/PKIA ceRNA network involving prognostic signatures in Hepatitis B virus-infected hepatocellular carcinoma.
Li G; Wang Z; Chen D; Yin J; Mo Z; Sun B; Yang T; Zhang X; Zhai Z; Li Y; Chen P; Dai Y; Wang Z; Ma J
Front Cell Infect Microbiol; 2022; 12():1025900. PubMed ID: 36204642
[TBL] [Abstract][Full Text] [Related]
2. LncRNA-Associated ceRNA Network Reveals Novel Potential Biomarkers of Laryngeal Squamous Cell Carcinoma.
Jing Z; Guo S; Zhang P; Liang Z
Technol Cancer Res Treat; 2020; 19():1533033820985787. PubMed ID: 33371795
[TBL] [Abstract][Full Text] [Related]
3. Potentials as biomarker and therapeutic target of upregulated long non-coding RNA HLA-F antisense RNA 1 in hepatitis B virus-associated hepatocellular carcinoma.
Zhang X; Li W; Li S; Zhang Z; Song W
Virus Genes; 2024 Jun; 60(3):243-250. PubMed ID: 38568442
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of ceRNA networks reveals prognostic lncRNAs related to immune infiltration in colorectal cancer.
Chen J; Song Y; Li M; Zhang Y; Lin T; Sun J; Wang D; Liu Y; Guo J; Yu W
BMC Cancer; 2021 Mar; 21(1):255. PubMed ID: 33750326
[TBL] [Abstract][Full Text] [Related]
5. Lnc-AIFM2-1 promotes HBV immune escape by acting as a ceRNA for miR-330-3p to regulate CD244 expression.
Xie C; Wang S; Zhang H; Zhu Y; Jiang P; Shi S; Si Y; Chen J
Front Immunol; 2023; 14():1121795. PubMed ID: 36845111
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of the TRHDE-AS1/hsa-miR-449a/ADAMTS5 axis as a novel prognostic biomarker in prostate cancer.
Lian X; Pang L; Zhou H; Liu S
Biofactors; 2024 May; ():. PubMed ID: 38818922
[TBL] [Abstract][Full Text] [Related]
7. Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network.
Dong Y; Wen W; Yuan T; Liu L; Li X
Dis Markers; 2023; 2023():1766080. PubMed ID: 36817087
[TBL] [Abstract][Full Text] [Related]
8. Genome-Wide Screening Identifies Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma.
Feng Y; Hu X; Ma K; Zhang B; Sun C
Biomed Res Int; 2021; 2021():6640652. PubMed ID: 34095306
[TBL] [Abstract][Full Text] [Related]
9. A prognostic four-gene signature and a therapeutic strategy for hepatocellular carcinoma: Construction and analysis of a circRNA-mediated competing endogenous RNA network.
Zhang HY; Zhu JJ; Liu ZM; Zhang YX; Chen JJ; Chen KD
Hepatobiliary Pancreat Dis Int; 2024 Jun; 23(3):272-287. PubMed ID: 37407412
[TBL] [Abstract][Full Text] [Related]
10. Analysis on EZH2: mechanism identification of related CeRNA and its immunoassay in hepatocellular carcinoma.
Zhao H; Liu H; Kang W; Zhan C; Man Y; Qu T
BMC Med Genomics; 2023 Aug; 16(1):201. PubMed ID: 37626362
[TBL] [Abstract][Full Text] [Related]
11. Construction of a TP53 mutation-associated ceRNA network as prognostic biomarkers in hepatocellular carcinoma.
Wang D; Shi W; Qiu C
Heliyon; 2024 May; 10(9):e30066. PubMed ID: 38737272
[TBL] [Abstract][Full Text] [Related]
12. miR-HCC2 suppresses hepatitis B virus replication by inhibiting the activity of the enhancer I/X promoter.
Gao H; Fan H; Xie H
Arch Virol; 2023 Oct; 168(11):282. PubMed ID: 37889339
[TBL] [Abstract][Full Text] [Related]
13. How CLSPN could demystify its prognostic value and potential molecular mechanism for hepatocellular carcinoma: A crosstalk study.
Shi Y; Wang Y; Niu K; Zhang W; Lv Q; Zhang Y
Comput Biol Med; 2024 Apr; 172():108260. PubMed ID: 38492457
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome-Wide Dynamics of m7G-Related LncRNAs during the Progression from HBV Infection to Hepatocellular Carcinoma.
Shi M; Zhu S; Sun L; Hu J; Li H; Dai W; Song N; Li M; Wu Y; Xu D; Guo T
Front Biosci (Landmark Ed); 2023 Dec; 28(12):339. PubMed ID: 38179760
[TBL] [Abstract][Full Text] [Related]
15. A prognostic model composed of four long noncoding RNAs predicts the overall survival of Asian patients with hepatocellular carcinoma.
Gu X; Li H; Sha L; Zhao W
Cancer Med; 2020 Aug; 9(16):5719-5730. PubMed ID: 32946170
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a prognostic signature based on fatty acid metabolism genes in HCC associated with hepatitis B.
Yan P; Luo Y; Huang Z; Mou T; Yang H; Peng D; Wu Z
BMC Gastroenterol; 2023 Nov; 23(1):390. PubMed ID: 37957550
[TBL] [Abstract][Full Text] [Related]
17. Identification of CD8
Li J; Chen H; Bai L; Tang H
BMC Cancer; 2024 Jan; 24(1):53. PubMed ID: 38200408
[TBL] [Abstract][Full Text] [Related]
18. ARID1A deficiency promotes progression and potentiates therapeutic antitumour immunity in hepatitis B virus-related hepatocellular carcinoma.
Xing T; Li L; Rao X; Zhao J; Chen Y; Ju G; Xu Y; Gao X; Dong G; Xia X; Guan Y; Zhang L; Wen Z; Liang J
BMC Gastroenterol; 2024 Jan; 24(1):11. PubMed ID: 38166741
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis identifies long non-coding RNA RNASEH1-AS1 as a potential prognostic biomarker and oncogenic target in hepatocellular carcinoma.
Sun J; Li Y; Tian H; Chen H; Li J; Li Z
Am J Cancer Res; 2024; 14(3):996-1014. PubMed ID: 38590422
[TBL] [Abstract][Full Text] [Related]
20. Identification of immune-related lncRNA in sepsis by construction of ceRNA network and integrating bioinformatic analysis.
Wang T; Xu S; Zhang L; Yang T; Fan X; Zhu C; Wang Y; Tong F; Mei Q; Pan A
BMC Genomics; 2023 Aug; 24(1):484. PubMed ID: 37620751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
